Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 68.95
+4.85 (7.57%)
Feb 21, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 61.89 billion as of February 21, 2025. Its market cap has increased by 75.82% in one year.
Market Cap
61.89B
Enterprise Value
62.16B
Revenue
2.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
68.95
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 61.89B, an increase of 233.73%. That is a compound annual growth rate of 28.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 61.89B | 13.59% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.72B |
| JD Health International | 117.55B |
| Hansoh Pharmaceutical Group Company | 117.50B |
| WuXi Biologics | 106.51B |
| Alibaba Health Information Technology | 97.13B |
| Innovent Biologics | 68.31B |
| Sinopharm Group | 61.79B |
| Sino Biopharmaceutical | 60.73B |